RAS as an ‘Undruggable’ Drug Target
New therapies are being developed to attack a previously untreatable cancer mutation.
Thanks to Lifesaving Cancer Research18,000,000cancer survivors in the United States are living with, through, and beyond their disease.
Your donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now